Mitera Biosciences
PrivateLast Round
Seed Round
May 6, 2026
Total Funding Raised
$1.75M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mitera Biosciences is a biotechnology company that develops investigational therapeutics for the treatment of autoimmune and alloimmune disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mitera Biosciences Comparables
Compare Mitera Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GentiBio | 81% | |
| RegCell, Inc. | 79% | |
| Egle Therapeutics | 78% | |
Mitera Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | May 6, 2026 | ||||
| Seed | Dec 30, 2025 |
Mitera Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cedars Sinai Health Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
Monthly visitors increased 177% MoM, reaching 1K.
- May 15, 2026
Monthly visitors grew 631% MoM, from 51 to 373.
Mitera Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mitera Biosciences's valuation, stock price, and market status.